See All Slides - tctmd.com

Slides

Presentation THT 2026

Virtual Randomized Clinical Trials: Learnings From DANLOGIC-HF

Presenter: Tor Biering-Sørensen

March 04, 2026

Presentation THT 2026

Emyosound Real-Time 3D Myocardial Shear Wave Elastography for Quantitative Assessment of Cardiac Stiffness in Heart Failure and Cardiomyopathies

Presenter: Thierry Sarda

March 04, 2026

Presentation THT 2026

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Presenter: Issa Dahabreh

March 04, 2026

Presentation THT 2026

Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support

Presenter: Sudhir Kushwaha

March 04, 2026

Presentation THT 2026

Opening Remarks

Presenter: Grzegorz L. Kaluza

March 04, 2026

Presentation THT 2026

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Presenter: Robert W. Yeh

March 04, 2026

Presentation THT 2026

Cutaneous device and machine learning could estimate pulmonary capillary wedge pressure in patients with heart failure

Presenter: Remi Sabatier

March 04, 2026

Presentation THT 2026

Time for a Separate Guideline Path for HF Devices?

Presenter: Javed Butler

March 04, 2026

Presentation THT 2026

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Presenter: David Israeli

March 04, 2026

Presentation THT 2026

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

Presenter: James Januzzi

March 04, 2026

Advertisement

Slides

Virtual Randomized Clinical Trials: Learnings From DANLOGIC-HF

Emyosound Real-Time 3D Myocardial Shear Wave Elastography for Quantitative Assessment of Cardiac Stiffness in Heart Failure and Cardiomyopathies

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support

Opening Remarks

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Cutaneous device and machine learning could estimate pulmonary capillary wedge pressure in patients with heart failure

Time for a Separate Guideline Path for HF Devices?

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content